Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India:…
Both drugs have seen a sharp decline in price since the availability of the first generic in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CIPREMI
Maha FDA files FIR against five people, guilty in blackmarketing of remedisivir and tocilizumab
The team seized medicines worth Rs 3,13,482 for COVID-19 and other therapeutic categories Amidst the rise of COVID-19 positive…
Remdesivir treatment gains popularity in India, black marketing and price cuts to continue:…
According to figures compiled by the CDSCO, India will be producing 20,000 vials per day by the end of July.
Cipla launches Cipremi, likely to price it Rs 4,000 per vial
It is looking to supply over 80,000 vials within the first month
Pharma firms initiate steps to curb black marketing of remedisivir
Measures include constant monitoring of the drug’s usage and ensuring its uninterrupted supply by working in collaboration with…
Sovereign Pharma releases first batch of remdesivir to Cipla
Cipla is likely to launch Cipremi in two to three days
Cipla to price remdesivir version for COVID-19 under 5,000 rupees
Cipla, in an e-mailed statement, did not provide details on when the treatment, called Cipremi, will be available
Cipla launches remdesivir under brand name CIPREMI
The product will be in the form of lyophilised powder for injection 100 mg